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Background: Increasing evidence indicates that neuroinflammation is a critical factor contributing to the
progression of various neurodegenerative diseases. The IKK/NF-κB signalling system is a central regulator of
inflammation, but it also affects neuronal survival and differentiation. A complex interplay between different
CNS resident cells and infiltrating immune cells, which produce and respond to various inflammatory mediators,
determines whether neuroinflammation is beneficial or detrimental. The IKK/NF-κB system is involved in both
production of and responses to these mediators, although the precise contribution depends on the cell type as
well as the cellular context, and is only partially understood. Here we investigated the specific contribution of
neuronal IKK/NF-κB signalling on the regulation of neuroinflammatory processes and its consequences. To address
this issue, we established and analysed a conditional gain-of-function mouse model that expresses a constitutively
active allele of IKK2 in principal forebrain neurons (IKK2nCA). Proinflammatory gene and growth factor expression,
histopathology, microgliosis, astrogliosis, immune cell infiltration and spatial learning were assessed at different
timepoints after persistent canonical IKK2/NF-κB activation.
Results: In contrast to other cell types and organ systems, chronic IKK2/NF-κB signalling in forebrain neurons of
adult IKK2nCA animals did not cause a full-blown inflammatory response including infiltration of immune cells.
Instead, we found a selective inflammatory response in the dentate gyrus characterized by astrogliosis, microgliosis
and Tnf-α upregulation. Furthermore, downregulation of the neurotrophic factor Bdnf correlated with a selective
and progressive atrophy of the dentate gyrus and a decline in hippocampus-dependent spatial learning. Neuronal
degeneration was associated with increased Fluoro-jade staining, but lacked activation of apoptosis. Remarkably,
neuronal loss could be partially reversed when chronic IKK2/NF-κB signalling was turned off and Bdnf expression
was restored.
Conclusion: Our results demonstrate that persistent IKK2/NF-κB signalling in forebrain neurons does not induce
overall neuroinflammation, but elicits a selective inflammatory response in the dentate gyrus accompanied by
decreased neuronal survival and impaired learning and memory. Our findings further suggest that chronic activation
of neuronal IKK2/NF-κB signalling, possibly as a consequence of neuroinflammatory conditions, is able to induce
apoptosis-independent neurodegeneration via paracrine suppression of Bdnf synthesis.
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Neuroinflammation is a common hallmark of several CNS
disorders, which is characterized by the upregulation of
proinflammatory cytokines and chemokines such as Tnf,
Ccl2 and Cxcl10 as well as the infiltration of activated
immune cells [1].
The activation of the NF-κB family of transcription
factors is a key step in the regulation of inflammatory
and immune responses. However, these proteins also
regulate gene expression in a variety of other physiological
processes like cell proliferation, differentiation and
survival, as well as specific CNS functions including
learning and memory [2]. In resting cells, NF-κB
dimers are sequestered in the cytosol by inhibitory
proteins of the IκB family. The crucial step in NF-κB
activation is the phosphorylation of IκB proteins by
the activating IκB kinase complex. IKK2 is the critical
kinase subunit inducing the canonical signalling path-
way, which is essentially involved in the regulation of
inflammation. Phosphorylation of inhibitory IκB proteins
initiates their ubiquitination and subsequent proteosomal
degradation, followed by the release and nuclear trans-
location of active NF-κB dimers, which then induce the
expression of NF-κB target genes [3-5].
Members of the IKK/NF-κB system are widely expressed
in the nervous system and different factors stimulate
NF-κB activation in the CNS, including damage-associated
molecular patterns, pathogen-associated molecular patterns,
cytokines, chemokines, neurotransmitters, neurotrophic
factors and neurotoxins. NF-κB is activated both under
physiological conditions, e.g. by synaptic activity, as well
as in pathological conditions [6-8]. Previous studies
reported that the IKK/NF-κB signalling system is
deregulated in various neuroinflammatory conditions
as Alzheimer’s disease (AD), Huntington’s disease (HD),
stroke, hydrocephalus and schizophrenia [9-15]. Depend-
ing on the cell type and pathophysiological context,
both protective and deleterious roles of NF-κB signalling
were found in CNS diseases, e.g. in ischemic injury [16,17].
We have previously shown that suppression of IKK/
NF-κB signalling in neurons reduces infarct formation in
an animal model of stroke. Vice versa ectopic activation
of IKK2 in a similar context increases the infarct size
after cerebral ischemia [9]. These findings indicate a
central role of neuronal NF-κB in the regulation of cell
survival in acute stroke pathogenesis.
In order to characterize the detailed role of neuronal
NF-κB in the pathogenesis of chronic neurodegenerative
disorders, we analysed the consequences of persistent
NF-κB activation in neurons using the IKK2nCA model. As
NF-κB activation is sufficient to induce strong inflamma-
tory processes in various cell types and tissues [11,18-20],
we particularly asked whether chronic NF-κB activation
in neurons is sufficient to drive a neuroinflammatoryresponse on its own and if so, what are the pathological
consequences.
Unexpectedly, IKK2nCA animals did not show massive
signs of neuroinflammation such as prominent proinflam-
matory cytokine expression and infiltration of immune
cells. Interestingly, they exhibited downregulation of
the neurotrophic factor Bdnf, which correlates with an
impairment of cognitive functions and degeneration of
the dentate gyrus.
Results
Conditional expression of IKK2-CA in principal
forebrain neurons
To study the consequences of chronic NF-κB activation
in forebrain neurons, we used the previously generated
IKK2nCA mouse model [9]. This conditional gain-of-func-
tion model co-expresses a constitutively active allele of
IKK2 (IKK2-CA) and a luciferase reporter gene under the
control of the Camk2a promoter in a tetracycline-regulated
manner (CamK2a-tTA x luciferase-(tetO)7-IKK2-CA, called
IKK2nCA) (Figure 1A). To avoid any influences of transgene
expression on brain development, animals were bred
and housed in the presence of doxycycline (DOX) up to
the age of 4 weeks.
To determine the transgene expression kinetics after
DOX withdrawal in IKK2nCA mice, we first analysed the
activity of the co-expressed reporter gene luciferase
using in vivo bioluminescence measurement (IVIS). We
found a CNS-restricted luciferase activity, beginning
within the first week of DOX withdrawal, which was then
stable for at least 8 months (Figure 1B and C), indicating a
rapid and robust transgene expression. To further analyse
the transgene expression pattern and its detailed spatial
resolution, we measured luciferase activity in protein
lysates from various brain regions and control organs.
As expected from the forebrain specific expression pattern
of Camk2a [21], luciferase activity depicted transgene
expression in the hippocampus, cortex, striatum and
olfactory bulb, but no or only a minor expression in
other brain regions and peripheral organs (Figure 1D).
Transgene expression was confirmed in the hippocampus,
striatum, and cortex by protein immunoblot analysis
(Figure 1E).
We next investigated cell type specificity of transgene
expression by immunofluorescence co-staining with the
neuronal marker NeuN. As shown for the hippocampal
CA1 region, expression of IKK2nCA was restricted to NeuN
positive neurons (Figure 1F). To assess the functional
consequences of IKK2-CA expression, subcellular localisa-
tion of the NF-κB subunit p65/RelA was analysed. RelA
staining revealed a strong nuclear reactivity in neurons
of the DG (Figure 1G) and of the CA1 region, cortex and
striatum of IKK2nCA mice (see Additional file 1) indicating
neuronal NF-κB activation in these animals. Moreover,
Figure 1 (See legend on next page.)
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Figure 1 Gain-of-function model for conditional IKK/NF-κB signalling in excitatory forebrain neurons. (A) Generation of the conditional
transgenic IKK2nCA mouse model using the tetracycline-regulated gene expression system (tet-off). The Camk2a promoter drives the expression of
the tetracycline transactivator protein (tTA). The tTA-activated promoter (7xtetO) directs the transcription of luciferase and the constitutively active
IKK2-CA allele (IKK2nCA). Doxycycline (DOX) administration blocks transgene expression. (B) In vivo luciferase measurement of IKK2nCA mice
indicates forebrain-restricted transgene expression (left panel). Luciferase expression (p/s/cm2/sr) showed rapid transgene expression already
within one week after DOX removal that sustains with age (right panel) (n = 14). (C) Robust transgene expression over time. 3M, 6M, 9M = 3, 6
and 9 month (n = 13). (D) Luciferase activity was measured in different organs and brain regions of 3M old mice. RLU/μg = relative light units
per μg protein (n = 4). (E) IKK2-CA transgene expression (hIKK2) was monitored in different brain regions of 3M old mice. Erk2 is used as loading
control (n = 3). (F) Immunohistochemical analysis of IKK2-CA expression (hIKK2, red; NeuN; green; 9M). Arrows indicate IKK2-CA expression in CA1
co-expressed with NeuN (yellow). DAPI (blue). Scale bar: 50 μm. (G) IKK2nCA mice (9M) show increased nuclear RelA staining in the DG. Inserts
depict magnification of marked areas. (H) Increased IKK activity in striatal lysates of IKK2nCA mice (3M) was monitored by in vitro kinase assay
using GST-IκBα as IKK substrate. Immunoprecipitated NEMO protein levels serve as loading control. (A-H) Co = wild type and single transgenic
littermates, IKK2nCA = mice with neuron-specific IKK2-CA expression. Hi, hippocampus; cx, cortex, str, striatum; Ol.B, Olfactory bulbi; H.thal,
hypothalamus; Thal, thalamus, M.B, midbrain; Cb, cerebellum; Med, medulla; Sp.co., spinal cord. All data are shown as mean ± SEM. All p-values
are derived from two-tailed-unpaired student’s t test.
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mice as measured by the phosphorylation level of the IKK
substrate GST-IκBα (Figure 1H).IKK2nCA mice do not show prominent signs of
neuroinflammation
NF-κB is the key regulator of inflammation [3], we there-
fore analysed the expression of proinflammatory factors,
in particular Tnf, Ccl2, Ptgs2 and Cxcl10, which are
well-characterized target genes of NF-κB [22]. In contrast
to other models [11,18-20,23], and with the exception of a
mild upregulation of Tnf and Cxcl10 in the hippocampus
of 3 months old IKK2nCA mice, no upregulation of Ccl2
and Ptgs2 could be detected (Figure 2A). We also did
not observe any elevation of other proinflammatory
factors like Ccl5 and Il6 (see Additional file 2A). To
further characterize inflammatory gene expression in
the CNS of IKK2nCA mice Tnf-α, co-immunostaining
with NeuN was conducted in different brain subregions.
Interestingly, Tnf-α immunoreactivity is especially in-
creased within hilar neurons of the DG, but not in the
CA1-region or in the cortex of 9 months old IKK2nCA
mice (see Additional file 2B). To confirm the subregion-
specific expression of Tnf RNA from the DG and Cornu
Ammonis (CA) region was isolated. Precise subregional
RNA isolation was certified by qRT-PCR analysis for the
DG-specific gene, Tryptophan 2,3-dioxygenase (Tdo2) and
the CA1-specific gene, Meis1-related protein 1b (Mrg1b)
(Additional file 2C) [24]. We observed an increase in
Tnf levels exclusively in the DG, which is lacking in the
CA-region. Cxcl10 expression shows a tendency to be
upregulated in both sub-regions, whereas Ccl2 and Il6 are
not altered at the age of 9 months (Additional file 2C).
Since neuroinflammation involves the activation of
microglia, we assessed their status in different forebrain
regions by Iba1 immunostaining. Consistent with the
results seen in Figure 2A, Iba1 staining only revealedselective microgliosis in the dentate gyrus (DG), whereas
other IKK2-CA-expressing brain regions like cortex and
the hippocampal CA1-region lacked microglial activation
at any timepoint analysed (Figure 2B-E). Astrocytes also
get activated under inflammatory conditions, a process
that is characterized by hypertrophic astroglia and an
upregulation of the astrocyte-specific intermediate filament
protein GFAP. Similar to the previous findings, astrogliosis
was detected only in the DG of IKK2nCA mice (Figure 2F,
G). We could not detect infiltration of CD45+ immune
cells and upregulation of Lcn2, an inflammatory marker
gene (Additional file 3) found in a different neuroin-
flammatory mouse model with immune cell infiltration
[11]. Therefore we conclude that IKK2-mediated NF-κB
activation in excitatory forebrain neurons is not sufficient
to induce a full-blown inflammatory response.Persistent IKK/NF-κB signalling interferes with
hippocampus dependent spatial learning
Several studies demonstrated that the IKK/NF-κB system
is involved in the regulation of neuronal differentiation
including neurite outgrowth, synaptic plasticity and synapse
formation [6-8,25,26]. As interference with IKK/NF-κB
signalling was found to impair learning and memory in
various experimental paradigms [26-33], we asked whether
there is an improvement of learning behaviour in our
gain-of-function model. For this purpose, IKK2nCA mice
were exposed to the Morris water maze task (MWM),
which is a test for hippocampus-dependent spatial learn-
ing [34]. Here, the animals were trained to find a hidden
platform in a water-filled pool within 60s (Figure 3A).
Both, control and IKK2nCA mice learned to find this plat-
form but IKK2nCA mice required longer time to navigate
and to reach the platform as compared to control litter-
mates (Figure 3B, C). This implied that persistent neuronal
IKK2/NF-κB activation does not enhance, but rather inter-
feres with spatial cognitive abilities in the MWM tasks.
Figure 2 (See legend on next page.)
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Figure 2 IKK2nCA mice show selective neuroinflammation. (A) mRNA was isolated from hippocampus of IKK2nCA mice and qRT-PCR analysis
for various cytokines dipicts mild upregulation of Tnf and Cxcl10 only at 3M, whereas there were no alterations for Ptgs2 and Ccl2. Data presented
are calculated relative to Hprt expression. (B) IKK2-CA induces microgliosis in the DG of IKK2nCA mice at 3M and 9M of age as represented by a
larger population of Iba-1-positive microglia. (C) Representative images of Iba-1 immunohistochemistry show comparable number of microglia in
the CA1-region of control and IKK2nCA mice at different ages. (D) Representative images of Iba-1 immunocytochemistry in brain sections indicate
a normal microglial morphology and density in cortex of IKK2nCA mice at different ages. (E) Quantification of Iba1 positive cells in control and
IKK2nCA mice at the age of 3, 6 and 9 months from B, C and D shows moderate microgliosis only in the DG, but not in the CA1-region and
cortex (n = 3-4). (F) IKK2nCA mice exhibit astrogliosis as shown by the increased reactivity in the DG by immunofluorescent staining for GFAP, the
astroglial marker (Age = 9M). GFAP positive area was measured using ImageJ64 software (n = 3). (G) Quantification of the GFAP positive area in
the DG represents significantly enhanced GFAP immunoreactivity at 3M and 9M, as well as a marked tendency of an increased GFAP positive
area at 6M, indicating astrogliosis (n = 3-4). Co =wild type and single transgenic littermate controls, IKK2nCA = transgenic mice with neuron-specific
expression of constitutively active IKK2. (B-D) Inserts at the right bottom depict the magnification of the marked areas. All data are shown as
mean ± SEM. All p-values are derived from two-tailed-unpaired student’s t test. * p < 0.05, ** p < 0.01. Scale bar: 50 μm.
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the forebrain of IKK2nCA mice
Since IKK2nCA mice exhibit deficits in spatial learning,
we addressed putative mechanisms possibly affecting
neuronal function, synaptic plasticity and cognition in
these animals. Therefore, we investigated the expression
of genes critically involved in the regulation of synaptic
plasticity, neuronal differentiation and survival [29,35-37].
Interestingly, we detected a reduced expression of the
neurotrophic factor Bdnf in hippocampal samples by
qPCR, whereas other neurotrophins (Ngf and Ntf3),
and memory-associated genes like Igf2 and Prkaca were
not deregulated (Figure 4A). To confirm this finding, we
also measured Bdnf levels by immunohistochemistry,
immunoblotting and ELISA. Indeed, a decreased Bdnf
reactivity could be observed in the hilus of the DG ofFigure 3 Forebrain-specific IKK2-CA expression impairs hippocampus
the Morris water maze paradigm. N, S, E and W mark the orientation of the
localised in the centre of the SW quadrant for eight consecutive training days
(B) Deficit in hippocampus dependent spatial learning of IKK2nCA mice is ded
MWM task as compared to the controls at 6M age (n = 14-16). (C) Impaired le
escape latency than the littermates during 8 days’ testing time (n = 13). (B-C)
unpaired student’s t test, Co =wild type and single transgenic littermate cont
constitutively active IKK2. All data are shown as mean ± SEM. ** p < 0.05, ** p <IKK2nCA mice already at the age of 3 months and also in
older animals (Figure 4B, C). DG-specific reduction of
Bdnf expression was confirmed by subregion-specific
mRNA expression analysis (Additional file 4). Moreover,
ELISA indicated a reduced level of Bdnf in cortex and
hippocampus at the age of 6 months (Figure 4D), which
was confirmed by immunoblotting in hippocampal and
cortical lysates at the age of 9 months (Figure 4E). One
effector function of Bdnf is the regulation of α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPAR) expression [38,39] and AMPAR subunits are
known to be expressed in the hippocampus [40]. Inter-
estingly, we observed a mild decrease in Gria1 and
Gria3 expression at 3 and 9 months of age, whereas no
obvious changes in Gria2 and Gria4 levels were noticed
(Figure 4F). Analysis of mRNA from the DG and CA--dependent spatial learning. (A) Scheme of a circular pond used for
pond. N (north), S (south), E (east) and W (west). The platform was
. Arrows mark the different starting positions used in the experiments.
uced from requirement of more time to find the hidden platform in
arning performance of 9M old IKK2nCA mice indicated by their longer
All mice were adult males. All p-values are derived from two-tailed-
rols, IKK2nCA = transgenic mice with neuron-specific expression of
0.01, *** p < 0.001.
Figure 4 Bdnf expression is decreased in the hippocampus and cortex of IKK2nCA mice. (A) qRT-PCR analysis indicates significantly reduced
levels of Bdnf mRNA in the hippocampus but no changes for the other analysed memory-associated genes as Ngf, Ntf3, Igf2 and Prkaca were detected
(n = 4-7). P-values are derived from two-tailed-unpaired student’s t test. (B) Representative images from immunostaining of IKK2nCA mice brains reveal a
decline in Bdnf immunoreactivity in the hilus of the dentate gyrus. Inward arrows point towards the expression of Bdnf in the hilus (n = 3-5). Scale bar:
100 μm. (C) Quantification of Bdnf immunoreactivity by ImageJ64 represents decreased Bdnf expression in the dentate hilus of IKK2nCA mice at 3M, 6M
and 9M age. p-values are derived from one way ANOVA Bonferroni’s Multiple Comparison test. (D) Measurement of Bdnf concentration by ELISA
indicates significant decrease in total Bdnf levels in the cortex and hippocampus of IKK2nCA mice at 6M of age (n = 4). P-values are derived from two-
tailed-unpaired student’s t test. (E) Western blot analysis demonstrates Bdnf reduction in cortex and hippocampus of IKK2nCA mice at the age of 9M.
Erk2 is used as loading control. (F) qRT-PCR shows that decreased Bdnf levels are associated with a reduced expression of Gria1 (GluR1) and Gria3
(GluR3) type AMPA receptors in the hippocampus at 3 and 9 months of age but no alterations are detected for Gria2 (GluR2) and Gria4 (GluR4) in all
three age groups. p-values are derived from two-tailed-unpaired student’s t test. (A-F) Co =wild type and single transgenic littermate controls,
IKK2nCA = transgenic mice with neuron-specific expression of constitutively active IKK2. All data are shown as mean ± SEM. * p < 0.05, ** p < 0.01.
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AMPA receptors in the IKK2nCA mice as compared to
the littermates. Gria1 reduction was also observed in
the CA-region, whereas Prkaca levels remain unaltered
(Additional file 4).
IKK2nCA mice develop a granular cell layer specific
degeneration of the dentate gyrus
We then asked whether the decreased Bdnf levels have any
effect on neuronal survival and analysed the hippocampi
of age-matched control and IKK2nCA mice by cresyl violet
staining.
Notably, we found a pronounced atrophy in both
blades of the DG of IKK2nCA at the age of 9 months
(Figure 5A). Immunostaining with the neuronal marker
NeuN indicated that atrophy depends on the loss of
neurons located in the granular cell layer (GCL) of the
dentate gyrus (Figure 5B), which is involved in regulation
of learning and memory in a Bdnf dependent manner [41].
The quantification of the neurons in the DG revealed a
progressive cell loss from 3 months to 9 months of age
(Figure 5C and D). The decrease in cell number gets
significant at 6 months when 20% of the cells are lost
in the lower blade, which at 9 months culminates to a
loss of 53% cells in the upper and 56% in lower blade.
Remarkably, analysis of apoptosis by cleaved caspase-3
immunofluorescent staining or TUNEL assay did not
reveal gross alterations between control and IKK2nCA
mice (Additional file 5). However, further analysis revealed
an increased number of Fluoro-jade-positive neurons and
neurites specifically in the DG of IKK2nCA mice but not in
the CA1, cortex and olfactory bulb (Additional file 6A-E).
These findings indicate that most of the deleterious
outcome associated with cell loss is due to apoptosis-
independent neuronal degeneration and is restricted to
the DG. Consistent with the lack of Fluoro-jade staining,
histological analysis did not show significant changes in
the thickness of primary cortex and granular cell layer
(GCL) of the olfactory bulbs (Additional file 7A-D). The
olfactory bulbs were also devoid of any changes in Bdnf
and RNA expression (Additional file 6F).
Bdnf is able to promote neuronal survival via the
expression of Bcl-2 [42]. In line with the pronounced loss
of neurons in the DG, we detected a downregulation of
Bcl2 and another important pro-survival gene, Bcl2l1
(Bcl-xL) at 9 months of age (Figure 5E). A subregion-
specific qRT-PCR analysis demonstrated a reduction of
Bcl2l1 both in the DG and CA of IKK2nCA mice whereas
Bcl2 expression was only tendentially decreased in this
analysis (Additional file 7E).
Replenishment of DG neurons by blocking IKK2-CA expression
Persistent neuronal IKK/NF-κB signalling resulted in an
age-dependent decline in cell number of the DG that isaccompanied by microgliosis, astrogliosis and reduced
Bdnf levels. To test whether this cell loss can be stopped
or reversed, we blocked transgene expression in IKK2nCA
mice at an age with prominent DG degeneration by DOX
application (Figure 6A). Downregulation of transgene
expression was monitored by IVIS and a complete absence
of the reporter gene luciferase was ascertained after 4 weeks
of DOX administration in IKK2nCA mice (Figure 6B).
Cresyl violet staining and cell counting demonstrated a
replenishment of neurons in the DG to 85% in the upper
and to 87% in the lower blade after 3 months of continu-
ous DOX treatment of IKK2nCA mice when compared
to the cell number of DOX treated control animals
(Figure 6C). Intriguingly, Bdnf levels also recovered in
the hilus region upon DOX application as compared to
control and untreated age-matched animals (Figure 6D).
When we monitored IKK2-CA transgene expression in
situ in this brain region, we identified only a limited
amount of IKK2-CA-positive cells in the hilus. This
finding suggests that the reduced Bdnf expression in the
hilus is not regulated directly by IKK2-CA but is rather
controlled in a paracrine fashion (Figure 6E).
To investigate potential mechanisms underlying the
structural reconstitution of the DG, we performed Ki67
staining, which indicated an increase in Ki67-immunore-
active cells in the DG of DOX treated IKK2nCA mice
(Additional file 8). This implies that IKK2-CA transgene
inactivation and subsequent regain of Bdnf expression
enhances adult neurogenesis in the GCL of the DG.Discussion
The IKK/NF-κB signalling system is proposed to be critic-
ally involved in the pathogenesis of various neurological
diseases [8]. On the one hand, it is well characterized as a
central regulator of inflammatory responses by controlling
the expression of multiple proinflammatory acting genes
[3,22]. On the other hand, IKK/NF-κB signalling is crucially
involved in neuronal differentiation and various CNS
functions [6-8]. However, due to its complex regulation
in different cell types and diverse responses to different
physiological and pathological conditions, the precise
function of the IKK/NF-κB system in CNS physiology
and pathology is only partially understood.
Former studies suggested an ambivalent role of the
IKK/NF-κB system in the pathogenesis of neurological
disorders [8,43]. Due to its proinflammatory function,
NF-κB activation is able to trigger neuronal dysfunction,
aging and cell death, thereby increasing severity of CNS
diseases [8,11,44,45]. In contrast, NF-κB activation can also
mediate neuroprotection [6,8,46]. Previously, we found that
IKK2/NF-κB activation in neurons increases tissue damage
in a mouse model of stroke, probably by enhancing the
overall neuroinflammatory process elicited by this acute
Figure 5 (See legend on next page.)
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Figure 5 IKK2-CA expression results in a degeneration of DG neurons in the GCL. (A) Nissl staining illustrates degeneration in the DG of
IKK2nCA mice at the age of 9M (n = 7). (B) Immunofluorescent staining of kryosections with NeuN (green) confirms that the cells lost in the
dentate gyrus are GCL neurons. Co-staining with DAPI (blue) was performed for visualising the nuclei (n = 3). (C) Representative images of
Nissl-stained sections depict a progressive, age-dependent degeneration in the DG of IKK2nCA mice from 3M to 9M of age (n = 6-8). (D)
Quantification of cell numbers in the CA1 region and DG manifest an ongoing cell loss specifically in both blades of the dentate gyrus in a
progressive manner (n = 6-8). (E) The anti-apoptotic genes Bcl2 and Bcl2l1 (Bcl-xL) are downregulated in the hippocampus of IKK2nCA mice at
9M as indicated by qRT-PCR analysis (n = 4-7). (A-E) Co = wild type and single transgenic littermate controls, IKK2nCA = transgenic mice with
neuron-specific expression of constitutively active IKK2. Scale bar: 50 μm. All data are shown as mean ± SEM. P-values are derived from two-tailed-
unpaired student’s t test. * p < 0.01.
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role of IKK2-mediated neuron-specific NF-κB activation
in the induction of neuroinflammatory responses using
the IKK2nCA model. We hypothesized that constitutive
IKK2 activation in neurons is sufficient to induce inflam-
mation, as it was demonstrated in several non-neural cell
types as well as in astrocytes [11,18-20,23]. However, with
the exception of microgliosis and astrogliosis observed
in the DG, neuron-specific IKK2 activation did not
result in a prominent inflammatory phenotype includ-
ing infiltration of immune cells. Consistently, typical
proinflammatory NF-κB target genes like Ccl2, Tnf,
Ptgs2, Lcn2 and Cxcl10 that are highly expressed in
other inflammatory conditions are either moderately or
not induced in the IKK2nCA model. This argues for a
specific function of IKK2/NF-κB signalling in neurons.
What could be the reason for this unexpected response?
As NF-κB is activated by synaptic signalling, such kind
of NF-κB activation in neurons would already create a
proinflammatory environment under the physiological
conditions of neurotransmission. Vice versa, inflammation-
mediated NF-κB activation in neurons would lead to
functional conflicts like deregulation of NF-κB-mediated
neurite outgrowth and synaptic plasticity. Therefore, a
functional separation of neuronal IKK/NF-κB signalling
versus inflammatory IKK/NF-κB signalling in other cells
could be of physiological advantage. Several studies showed
important functions of NF-κB in neuronal differentiation,
including neurite outgrowth, formation and remodelling
of synaptic connections, axogenesis and neuronal func-
tion, e.g. hippocampal learning and memory formation
[6,26,28,47-50]. These studies are mainly based on experi-
mental approaches inhibiting the IKK/NF-κB signalling
system in neurons, therefore it could be anticipated
that neuronal IKK/NF-κB activation might result in a
phenotype that improves neuronal survival and cognitive
capabilities. However, this idea appears to be in stark
contrast to our findings. One plausible explanation for
this discrepancy could be the duration of IKK/NF-κB
signalling. In our model we induce permanent IKK/NF-κB
activation over weeks, whereas in the physiological context
of learning and memory rather a transient or repetitive
activation is known to occur which is e.g., elicited bythe neurotransmitter glutamate, known to induce NF-κB
in synaptic signalling [51,52]. As excessive glutamate
signalling results in excitotoxic cell death [53], we can
speculate that the constitutive NF-κB activation in our
model is probably detrimental to the DG neurons.
Interestingly, pharmacological inhibition of IKK2 was
able to block NMDA-induced excitotoxic cell death in
hippocampal neurons and oligodendrocytes [54]. In
line with the view that especially a transient NF-κB
activation kinetic improves neuronal differentiation,
Russo et al. shows that stereotactic application of a virus
expressing IKK2-CA to the nucleus accumbens leads
to spine formation within a short time of 3 days [50].
The adequate function of the adult dentate gyrus
depends on both healthy mature granule cells as well
as ongoing neurogenesis [55] and NF-κB was shown
to be critically involved in different aspects of adult
neurogenesis using loss-of-function approaches [28,56].
Since we only see neurodegeneration in the DG, a
hypothesis might be that constitutive IKK2 activity
also interferes with neurogenesis, which then results
in a depletion of neurons in the GCL. However, a
roughly 50% reduction in the cell count at 9M is dif-
ficult to explain solely by blockade of ongoing adult
neurogenesis in the IKK2nCA model but rather suggests
active neurodegeneration. Furthermore, we could ob-
serve increased evels of Ki67-positive cells upon trans-
gene inactivation arguing for elevated neurogenesis
that may account for an active regeneration process
of the DG rather than simple prevention of further
neurodegeneration.
Imielski et al. [28] showed that the structural degener-
ation of the DG depends on apoptotic cell death, which
was not detected in our model as measured by cleaved
caspase-3 and TUNEL assay (Additional file 5). Instead,
we could identify degenerating neurons in the DG but not
in other brain regions by Fluoro-jade staining suggesting
that IKK2-CA induces cell death but this cell death is
independent of apoptosis or is due to a very slow rate
of apoptosis that may escape detection. So far it
remains largely open why this degeneration process
is specific to the DG. However, our findings implicate
that a combination of Bdnf decrease and Tnf increase
Figure 6 (See legend on next page.)
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Figure 6 DOX administration turns off transgene expression and restores the structure of the dentate gyrus in IKK2nCA animals. (A)
Experimental design indicating schedule of DOX administration to mice for transgene inactivation. (B) Representative image of Co and IKK2nCA
animals (treated as indicated) obtained by IVIS (upper panel). Quantification of in vivo luciferase activity demonstrates inactivation of transgene
expression in IKK2nCA mice by DOX application (lower panel; n = 4). All p-values are derived from two-tailed-unpaired student’s t test. (C) Cresyl
violet stained sections show restoration of the DG morphology in IKK2nCA mice after administrating DOX for 3 months. Quantification of cell
number reveals that the number of neurons in GCL of IKK2nCA mice recovers upon DOX treatment. All p-values are derived from two-tailed-unpaired
student’s t test (n = 4). (D) Representative images from DG of IKK2nCA mice indicate reversal of Bdnf expression after transgene inactivation. Arrows are
pointing towards the hilus of the DG indicating Bdnf expression. Quantification of Bdnf immunoreactivity indicates reversal of Bdnf expression in the
dentate hilus of IKK2nCA mice after DOX treatment. P-values are derived one-way ANOVA Bonferroni’s Multiple Comparison test (n = 4). (E)
Co-immunostaining of brain sections with hIKK2 transgene (red), and NeuN (green) demonstrating that only GCL neurons express hIKK2 (white arrows)
whereas NeuN positive neurons in the hilus of DG (arrow heads) do not show any transgene expression (co-expression is shown in yellow). All
fluorescent images show DAPI (blue) costaining. (A-E) Co = wild type and single transgenic littermates, IKK2nCA = transgenic mice with
neuron-specific expression of constitutively active IKK2. Scale bars: B, E: 50 μm, C: 100 μm. All data are shown as mean ± SEM. * p < 0.05, ** p < 0.01.
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account for the selective neurodegeneration of the dentate
gyrus in the IKK2nCA model. The structural restoration
of the dentate gyrus after transgene inactivation in both
models implies that fine balanced levels of NF-κB are
required for appropriate neuronal survival and homeo-
stasis in this brain region. Therefore, reactivation of
the IKK/NF-κB system for therapeutic measures of
neuro-regeneration in the context of dementia-associated
diseases as suggested by Imielski et al. [28] is apparently
critical and surely dose-dependent.
The neurodegenerative effect of constitutive IKK2
signalling could be due to the composition of the
activated NF-κB dimers. In IKK2nCA mice the canonical
NF-κB pathway is active, most likely leading to the nuclear
translocation of p65 containing dimers that are found
to regulate apoptosis associated genes [57]. Also, there
might be an under-representation of c-Rel containing
dimers, which are known to promote neuronal survival
by enhancing Bcl2l1 transcription [57]. Corresponding to
this, a downregulation of pro-survival genes like Bcl2
and Bcl2l1 was detected at older age in IKK2nCA mice,
although both of these are regulated by NF-κB [58,59].
Moreover, the decreased Bdnf expression in IKK2nCA
mice can be proposed as a potential mechanism that
interferes with neuronal survival [60] because it also
correlates with a decline in Bcl2 and Bcl2l1 levels [42].
Bdnf is well known to regulate cognitive tasks, synaptic
plasticity and neuronal survival by activating its receptor
TrkB [39,41,60,61] and its expression is compromised in
brain disorders as AD, HD, Rett syndrome and schizo-
phrenia [62,63]. Thus, the reduced levels of Bdnf and
Bdnf-regulated AMPA receptors might attribute to the
impaired hippocampal learning and the atrophy of the DG
observed in our model.
Nevertheless, other factors may also contribute to the
impaired learning and atrophy of the dentate gyrus. There
is the possibility that the microgliosis and astrogliosis
observed in the DG are sufficient to cause the neu-
rodegeneration in IKK2nCA mice [64,65]. Together with theelevated Tnf levels, such kind of inflammatory processes
may influence learning and memory as well as neuronal
survival. This might contribute to the observed phenotype,
although the importance of low-grade neuroinflammation
for learning and memory and neurodegeneration is still
controversially discussed [66].
What is the underlying molecular mechanism resulting
in reduced Bdnf, Bcl2 and Bcl2l1 expression in IKK2nCA
mice? The observed downregulation for Bdnf is rather
surprising, as Bdnf is an NF-κB target gene in astrocytes
[67] and would therefore expected to be rather upregulated
in neurons, too. Although we did not investigate the
mechanism behind this repression of Bdnf in IKK2nCA
mice, previous studies identified a similar kind of down-
regulation of target genes by NF-κB, e.g. in the case of
hypoxia, Tnf-dependent EAAT2 expression, or in the
regulation of anti-apoptotic genes after treatment of
cells with DNA-damaging agents [68-70]. Campbell et
al. showed that the cytotoxic stimuli like ultraviolet
light (UV-C), and daunorubicin, downregulated the
expression of anti-apoptotic NF-κB target genes like
Bcl2, Bcl2l1, Xiap and A20, thus providing the possibility
that canonical NF-κB activation may account for induc-
tion and repression of target genes depending on the
presence of coactivators, given cell type and induction
mechanism [69]. There is also the possibility that NF-
κB mediated changes in epigenetic gene regulation may
affect Bdnf expression [71-73]. Moreover, IKK2 has
been previously described to phosphorylate Bcl-xL, a
mechanism associated with reduced expression of this
gene in stressed, post-mitotic neurons [10]. A recent
publication by Zhang et al. [45] addressed the role of
IKK2/NF-κB signalling in the hypothalamus, which
increases with aging and mediates suppression of
hypothalamic-gonadotropin-releasing hormone (GnRH1)
expression finally promoting systemic aging. They found
that elevated IKK2 and NF-κB activity induces cJun/cfos
and PKC levels, which are able to inhibit Gnrh1 promoter
activity. This mode of NF-κB-mediated inhibition of gene
expression might also account for NF-κB-mediated Bdnf
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by multiple promoters.
More importantly, the IKK2-CA transgene and Bdnf
expression pattern do not coincide very well in the DG
of IKK2nCA mice (Figure 6D). Bdnf expression is located
to the hilus region whereas IKK2-CA protein is detected
in GCL neurons. In support of this, GABAergic interneu-
rons present in the hilus are devoid of Camk2a expression
thereby excluding Camk2a-driven transgene expression
in these neurons [74]. This strongly argues for a scenario
that IKK2-CA mediated NF-κB activation does not
directly influence Bdnf expression. Rather, a so far
unknown factor/s released by IKK2-CA positive neurons
suppresses Bdnf production in a paracrine manner in
the vicinity of the hilus, a process that necessarily does
not depend on NF-κB-mediated gene regulation.
Notably, recent work by Han et al. reported that the
Camk2a-tTA transgene, also used in the present study to
drive IKK2-CA expression, itself exhibits a degenerating
effect on the neurons which was not recognized by the
scientific community for many years. Moreover, they
observed that this degeneration was permanently rescued
by administration of DOX during the first 6 weeks of life
[75]. As the IKK2nCA animals were treated with DOX
up to the age of 4 weeks, most likely, we also avoid the
tTA-induced degeneration. Consistent with that, the
Camk2a-tTA-induced neurodegeneration gets obvious
already at the age of 2 months, whereas a IKK2nCA animals
do not show atrophy up to the age of 3 months rather
develop degeneration between 3 and 6 month age periods.
Furthermore, IKK2nCA animals were bred in pure NMRI
background, an outbred model, which is different from
the analysed hybrid strains sensitive for tTA-induced
degeneration.
Conclusion
In the present study we demonstrate that chronic acti-
vation of IKK2/NF-κB signalling in excitatory forebrain
neurons does not induce a self-propagating inflam-
matory response including immune cell infiltration, as
observed in other model systems. Instead, it interferes
with spatial learning concomitant with decrease in Bdnf
levels and neurodegeneration in the DG. Furthermore,
we propose a novel mechanism of IKK/NF-κB dependent
regulation of neuronal homeostasis and function, in
particular a paracrine downregulation of Bdnf expression
leading to impaired learning capabilities and dentate gyrus
degeneration. Remarkably, our reverse remodelling results
clearly show the high structural plasticity of the DG
even in elderly animals. To what extent Bdnf depletion
by enhanced neuronal IKK2/NF-κB activation is relevant
to the pathogenesis of neurological disorders is an
interesting question arising from this study, which
with further elucidation can provide valuable insightsto develop therapeutic strategies for neurodegenerative
diseases.Materials and methods
Transgenic mice
Mice were kept in a specific pathogen-free (SPF) animal
facility at University of Ulm. Double transgenic mice
(CaMK2a-tTA x luciferase-(tetO)7-CA-IKK2) were gener-
ated by directly crossing CaMK2a-tTA mice with single
transgenic mice carrying a luciferase-(tetO)7-IKK2-CA
transgene. The latter mice have a bidirectional promoter
(tetO)7 which regulates the expression of luciferase re-
porter gene as well as IKK2-CA [9]. Both single transgenic
mouse lines were bred on the NMRI background. In order
to avoid any interference with brain development, inacti-
vation of transgene expression was carried out by adminis-
tration of DOX (0.1 g/l, MP Biomedicals) in 1% sucrose,
in the drinking water to the dams during pregnancy, and
to pups until 4 weeks of age. As control animals usually
(tetO)7-IKK2-CA single transgenic littermates were used.
Genotyping was made by PCR.
All animal experiments were performed in compliance
with the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health and
the German Animal Protection Act and was approved
by the Regierungspräsidium Tübingen, Germany that is
the responsible government agency for animal rights.In vivo bioluminescence assay
Images for brain localized transgene expression were
obtained with IVIS 200 System (Caliper) by performing
IVIS as described by [76] and [77].Luciferase assay
For the detection of transgene, the tissue samples were
snap frozen in liquid nitrogen, and the extracts were
prepared by homogenizing the pulverized tissue in TNT
extraction buffer. Luciferase reporter assay was performed
as previously described [76].Immunoblotting
Native tissue protein extracts were prepared as described
previously [18]. Equal amounts (50 μg) of total proteins
were resolved on SDS-PAGE gels and transferred to
nitrocellulose membranes by a standard western blot
protocol. Membranes were then blocked with 5% non-fat
dry milk in TBS buffer for 1 h at room temperature.
Incubation with primary antibody (see below) was per-
formed in blocking solution overnight at 4°C or for 2 h at
room temperature. After washing with TBS, incubation
with the HRP coupled secondary antibody was performed
for 1 h at room temperature.
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from Invitrogen for the detection of signals. The “In-
telligent Dark Box” (Fuji) was used to reveal the lu-
minescence signals.
Histology and immunostaining
For the histopathological analysis, animals were perfused
with PBS and 4% PFA and decapitated. Brains were then
fixed by immersion in 4% PFA (3-4 h at room temp-
erature), dehydrated, embedded in paraffin, and cut to
7 μm thick coronal sections using the microtome Microm
HM355S (Thermo Scientific, Waldorf, Germany). For
making cryosections, the brains were frozen as described
by [76] and the frozen brains were sectioned to 8 μm thick
slices using cryotome Leica CM1900 (Leica Microsystems,
Wetzlar, Germany). To identify the morphology of brain,
nissl staining was performed with the paraffin sections.
For immunofluorescent staining, after rehydration, heat
mediated antigen retrieval was performed with sodium
citrate (10 mM, pH 6, 0.05% Tween 20) or Tris-EDTA
(10 mM Tris, 1 mM EDTA, pH 9, 0.05% Tween 20)
and for full permeabilization sections were incubated
with 0.5% Triton X-100 for 30 min. Sections were
washed with PBS and blocked with 5% BSA with Fc
Block antibody (BD Pharmingen, dilution 1:100) for 1h.
Incubation with the primary antibodies (in 5% BSA)
was performed overnight at 4°C, secondary antibodies
were applied for 1h at room temperature with DAPI for
nuclear counterstaining. For GFAP, cleaved caspase-3
and CD45 staining, the cryosections from natively frozen
brains were fixed with cold methanol (-20°C). Blocking
and staining was performed as described above. Fluor-
escence images were acquired with the Zeiss Axiovert
200 M microscope with filters for DAPI, FITC/Alexa
Fluor 488, and TexasRed/Alexa Fluor 568/594 and the
Zeiss Axiovision software. For every channel exposure
times were adjusted separately and kept same for the
complete session. Adjustment of contrast and brightness
was performed distinctly for each channel, but equally in
all compared pictures.
For immunohistochemistry, paraffin sections were treated
with 3% hydrogen per oxide, heat mediated antigen
retrieval was performed with citric acid buffer (pH 6.0),
washed with TBS and blocked with 5% BSA for 1h at
room temperature. Afterwards, slides were incubated with
the primary antibodies against Iba1, RelA or Bdnf over
night at room temperature. Biotinylated rabbit secondary
antibody was applied for 30 min at room temperature,
subsequently slides were treated with streptavidin HRP
and the signals for Iba-1 were obtained using DAB,
whereas by AEC reagent for RelA and Bdnf.
Fluoro-jade B staining was carried out with the cryosection
of animals perfused with 4%PFA as described by [78].
Images were obtained by Leica CTR5500 microscope.Antibodies for immunostaining and immunoblotting
Goat anti-human IKK2 (sc-7329), rabbit anti-RelA (sc-372),
rabbit anti-Bdnf (sc-546), rabbit anti-Erk2 (sc-154) and
HRP-conjugated goat anti-rabbit or donkey anti-goat
were obtained from Santa Cruz Biotechnology. Mouse
anti-NeuN from Millipore (MAB 377), rabbit anti-GFAP
from Abcam (Ab56777), rabbit anti-Cleaved-caspase3 from
cellsignalling (9661), rat anti-CD45 from BD Pharmingen
(BD550539) and rabbit anti-Iba1 was obtained from
WAKO (019-19741).
Alexa Fluor labelled secondary antibodies were obtained
from Invitrogen, DAPI was purchased from MERCK, and
biotinylated anti-rabbit from VECTOR Laboratories U.S.A.
TUNEL assay
TUNEL Assay was performed with paraffin sections using
the Calbiochem TUNEL Assay kit, according to the man-
ufacturer’s instructions.
Kinase assay
Kinase assay was performed to measure basal IKK activity.
The IKK complex was immunoprecipitated from striatal
lysates with an antibody recognizing NEMO using protein
A beads. The in-vitro-kinase assay was done as described
in [9], taking recombinant GST-IκBα as substrate. Radio-
labelled ATP was used, whose γ-Phosphate is transferred
to the substrate GST-IκBα in the presence of the IKK
complex proportional to its activity. Kinase activity was
determined by detection of radiolabelled GST-IκBα after
SDS-PAGE and western blot. For loading control, NEMO
levels were detected in the precipitates by immunoblot.
RNA extraction, cDNA synthesis and qPCR
RNA from hippocampus and cortex was isolated with
the PeqGOLD Trifast (peQlab) kit from the frozen tissue
pulverized with a morter and pestle under liquid nitrogen.
cDNA was synthesized using Roche Transcriptor High
fidelity cDNA synthesis kit with 0.8 μg of total RNA
and oligo-dT-primers according to the manufacturer’s
instructions. Quantitative Realtime-PCR assays were
performed with the Lightcycler 480 Instrument (Roche
Applied Science) with primers and hydrolysis probes
designed by the Roche Universal Probe Library system.
Hypoxanthine-guanine phosphoribosyltransferase gene
(Hprt) was used as housekeeping gene.
Primer sequences and UPLs used for the quantitative
real time PCR are as follows: Hprt (5′-GGA GCG GTA
GCA CCT CCT-3′, 5′- CCT GGT TCA TCA TCG
CTA ATC-3′, UPL no. 69), Tnf (5′- TGC CTA TGT
CTC AGC CTC TTC-3′, 5′- GAG GCC ATT TGG
GAA CTT CT-3′, UPL no. 49), Ccl2 (MCP1) (5′- CAT
CCA CGT GTT GGC TCA-3′, 5′- GAT CAT CTT
GCT GGT GAA TGA GT-3′), Cxcl10 (IP10) (5′- GCT
GCC GTC ATT TTC TGC-3′, 5′ TCT CAC TGG CCC
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GCT CTT CCG AGC TGT G-3′, 5′- GGA TTG GAA
CAG CAA GGA TTT - 3′, UPL no. 45), Bdnf (5′-AGT
CTC CAG GAC AGC AAA GC-3′, 5′-TGC AAC CGA
AGT ATG AAA TAA CC-3′, UPL no. 31), Ngf-β (5′-AAT
TAG GCT CCC TGG AGG TG-3′, 5′-TGG ACT GCA
CGA CCA CAG-3′, UPL no. 22), Ntf3 (5′-CGA CGT CCC
TGG AAA TAG TC-3′, 5′-TGG ACA TCA CCT TGT
TCA CC-3′, UPL no. 29), Igf2 (5′-CGC TTC AGT TTG
TCT GTT CG-3′, 5′-GCA GCA CTC TTC CAC GAT
G-3′, UPL no. 40), Prkaca (PKA catalytic α) (5′-GGC
TCT CGG AGT CCT CAT C-3′, 5′-CAG AGC TGA
AGT GGG ATG G-3′, UPL no. 46) Gria1 (GluR1) (5′-
AGG GAT CGA CAT CCA GAG AG-3′, 5′- TGC
ACA TTT CCT GTC AAA CC-3′, UPL no. 62), Gria2
(GluR2) (5′- CCA ATG GGA TAA GTT CGC ATA-3′,
5′- GCA CAG CTT GCA GTG TTG A-3′, UPL no.
110), Gria3 (GluR3) (5′- AAG CCG TGT GAT ACG
ATG AA-3′, 5′- TGC CAG GTT AAC AGC ATT
TCT-3′, UPL no. 31), Gria4 (GluR4) (5′- CTG CCA
ACA GTT TTG CTG TG-3′, 5′- AAA TGG CAA
ACA CCC CTC TA -3′, UPL no. 48), Bcl2 (5′- GTA
CCT GAA CCG GCA TCT G -3′, 5′-GGG GCC ATA
TAG TTC CAC AA-3′, UPL no. 75), Bcl2l1 (Bcl-xL)
(5′- TGA CCA CCT AGA GCC TTG GA - 3′, 5′- TGT
TCC CGT AGA GAT CCA CAA - 3′, UPL no. 2), Il6
(5′- CT ACC AAA CTG GAT ATA ATC AGG A - 3′,
5′- CCA GGT AGC TAT GGT ACT CCA GAA-3′,
UPL no. 6),), Ccl5 (RANTES) (5′- TGC AGA GGA
CTC TGA GAC AGC - 3′, 5′- GAG TGG TGT CCG
AGC CATA - 3′, UPL no. 110), Tdo2 (5′- AAT CAG
AGC AGG AGC AGA CG - 3′, 5′- TTG GCT CTA
AAC CAG GTG TTC -3′, UPL no. 22), Mrg1b (5′- AGA
CAA GGA CGC AAT CTA TGG - 3′, 5′- GCT CGC
ACT TCT CAA AAA CC -3′, UPL no. 6) and Lcn2 (5′-
CCA TCT ATG AGC TAC AAG AGA ACA AT - 3′, 5′-
TCT GAT CCA GTA GCG ACA GC -3′, UPL no. 58).BDNF quantification
BDNF positive area was measured using ImageJ64 soft-
ware. BDNF negative area was cut from the photomi-
crographs, subsequently, quantification was made at a
particular threshold level by measuring BDNF positive
area in the specific (red) channel.Quantification of astrogliosis
GFAP positive area was measured using ImageJ64 soft-
ware. The background was subtracted after importing the
images in ImageJ64. Similar threshold level was set for
every image, on the dark background (in the particular
channel; texas red) and the positive signals were
quantified.Quantification of microglia and Ki67 positive cells
Iba1-positive microglia were counted in two fields of
cortex, CA1 region and dentate gyrus per mouse. Ki67-
positive cells were counted in two fields of dentate
gyrus for every animal in each age group. Images were
obtained using Leica CTR5500 microscope. Cell count
was performed manually using ImageJ64 software.
Quantification of nuclear cells in the dentate gyrus and
CA1 region
Cresyl violet stained images were obtained from control
and transgenic mouse brain sections. Particular areas
were defined in the CA1 region and in the upper and
lower blades of the dentate gyrus for quantification of
cell number. Nine coronal planes were selected from
rostral to caudal part of brain (bregma: ~ 1.46, 1.70,
1.82, 2.06, 2.18, 2.30, 2.54, 2.80, and 3.08 mm according
to ref. [79] to ensure similar topography and avoid errors
due to the differences in orientation of planes. Cells were
counted in the specified areas of matched planes using
ImageJ64 software. Percentage cell loss was determined
with respect to the cell number in the control animals.
Primary cortex was measured (bregma: ~ 4.98 mm) with
ImageJ64. Images for olfactory bulbi were taken at
bregma: ~ 4.28 mm.
Bdnf ELISA
ELISA for Bdnf was performed with Promega (Madison,
WI, USA) ELISA kit. Protein extracts from cortex and
hippocampus were made in the lysis buffer as described
by Promega (1% Nonidet P-40, 20 mM Tris, pH 8.0, 137
mM NaCl, 10% glycerol, 1 mM phenyl-methylsulfonyl
fluoride, protease inhibitor Complete mini (Roche),
0.5 mM sodium vanadate). The procedure was made
according to the manufacturer’s instructions.
Morris water maze task
The experimental subjects were 6 and 9 month old male
mice (Co group, n = 13 IKK2nCA, (n = 13), which were
housed individually in a 12 h light/dark schedule for one
week before the Morris water maze (MWM) task was
performed to get familiar with the place. Mice were
habituated to handling by the experimenter at least for
three days before the experiment. The experiment was
performed as described by Vorhees and Williams [34]
with some modifications; the animals were exposed to
this spatial learning paradigm for eight consecutive days
with four trials per mouse each day with an inter trial
interval of 15 min. Visual cues were provided outside
the pool on the walls of the room to help in navigation.
Position of platform was kept same throughout the
training session, however, each day the start locations
for the trials were random. For all days, the experiment
was performed at the same time of the day with the
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proof and the experimenter was blind about the genotypes
of mice. Before the MWM task, a visible platform test was
performed to exclude motor and visual acuity impairment.
The platform was marked with a flag, and tracking length
and latency to reach the platform were recorded.
All data including track length, position of the animals
and latency to find the hidden platform were recorded
using an automated video tracking and analysis system,
Viewer II software, (Biobserve, Bonn, Germany).Statisticical analysis
Statistical analysis was performed with the Prism-software
(Graphpad). All data are shown as mean ± SEM. Statistical
significances were determined by using unpaired Student’s
t test or as stated in the figure legends. (* p < 0.05; ** p <
0.01; *** p < 0.001).Additional files
Additional file 1: IKK2-CA expression results in nuclear RelA
localization in different forebrain-regions. Immunohistochemistry of
RelA depicts enhanced nuclear localisation of RelA in the DG, CA1-region,
cortex and striatum of transgenic mice compared to controls (Age = 9M).
Co =wild type and single transgenic littermate controls, IKK2nCA = transgenic
mice. Scale bar: 50 μm. (n = 3).
Additional file 2: Tnf-α immunoreactivity is increased in the DG of
IKK2nCA mice. (A) qRT-PCR analysis indicates that Ccl5 and Il6 are not
deregulated in the hippocampal mRNA of IKK2nCA mice at any timepoint.
ns = non-significant. P-values are derived from two-tailed-unpaired
student’s t test. (B) Representative images of Tnf-α (green)
immunofluorescence stainings showing stronger immunoreactivity in the
hilar neurons (NeuN) of the transgenic dentate gyrus (DG) as compared
to the control littermates at the age of 3 months. (Coexpression of Tnf-α
and NeuN is shown in yellow). Sections are costained with DAPI (blue)
for visualising the nuclei. Inserts depict the magnification of the marked
areas (n = 4). Scale bar: 50 μm. (C) qRT-PCR analysis of Tdo2 (DG marker
gene) and Mrg2b (CA1 marker gene) assure correct subregion isolation.
The levels of Tnf are specifically high in the DG of IKK2nCA mice, Cxcl10
shows a tendency of upregulation in both DG and CA, whereas Ccl2 and
Il6 are not deregulated in either region of IKK2nCA mice (n = 6). P-values
are derived from two-tailed-unpaired student’s t test. Co = wild type and
single transgenic littermate controls, IKK2nCA = transgenic mice with
neuron-specific expression of constitutively active IKK2. All data are
shown as mean ± SEM. ** p < 0.05, ** p < 0.01, *** p < 0.001.
Additional file 3: Analysis of infiltration of CD45-positive cells. (A-C)
Kryosections stained for CD45 do not reveal obvious immune cell
infiltration in the IKK2nCA model. Photomicrographs of 3, 6, 9M old
control and IKK2nCA mice indicate CD45+ cells in the (green). DAPI (blue)
costaining is used for visualising the nuclei. Inserts at the right bottom
depict the magnification of the marked areas. Scale bar: 50 μm, (n = 3-4).
(D) mRNA analysis of Lcn2 shows no upregulation in the DG or CA1-
region of IKK2nCA mice as compared to the control littermates. Co = wild
type and single transgenic littermate controls, IKK2nCA = transgenic mice
with neuron-specific expression of constitutively active IKK2 (n = 3-4).
Additional file 4: Subregional analysis of learning-associated genes.
qRT-PCR analyses indicate DG-specific downregulation of Bdnf and Gria3
in IKK2nCA mice. However, Gria1 levels are reduced in both DG and
CA1-region, whereas Prkaca is not deregulated in the IKK2nCA mice as
compared to the littermate controls (age = 9M). Co = wild type and single
transgenic littermate controls, IKK2nCA = transgenic mice with neuron-
specific expression of constitutively active IKK2 (n = 6).Additional file 5: IKK2nCA mice do not show apoptosis in the CNS.
(A-C) Analysis of apoptosis by cleaved caspase-3 staining.
Photomicrographs from the DG, hippocampus CA1 and cortex of 3, 6,
9M old control and IKK2nCA mice indicate no caspase-3 (red) positive
cells. Sections are stained with DAPI (blue) for visualising the nuclei
(n = 4). (D) TUNEL assay was performed with paraffin sections from the
hippocampus of age-matched control and transgenic mice at the age of
3, 6, and 9M. Similar number of TUNEL-positive cells was observed
between both genotypes. Inserts at the right bottom demonstrate the
magnification of the marked areas (n = 4). Co = wild type and single
transgenic littermate controls, IKK2nCA = transgenic mice with
neuron-specific expression of constitutively active IKK2. Scale bar: 50 μm.
Additional file 6: Fluoro-jade B staining indicates degeneration of
neurons in the DG of IKK2nCA mice. (A-C) Fluoro-jade (green) positive
cells and neurites are indicated. Sections are stained with DAPI (blue) for
visualising the nuclei. Arrow heads point towards the degenerating
neurites, whereas the arrows point towards the degenerating neurons.
Inserts depict the magnification of the marked areas. (D) Fluoro-jade
(green) positive cells and neurites are counted in the DG, CA1, and cortex
of transgenic mice and control littermates. Dentate gyrus of IKK2nCA mice
shows a high number of degenerating cells and their processes as
marked by FJ-B staining in all age groups. (E) Olfactory bulbs of control
and IKK2nCA mice are deficient of Fluoro-jade positive cells. (F) qRT-PCR
analysis for Bdnf and Tnf expression reveals no changes in the olfactory
bulbs. Co = wild type and single transgenic littermate controls, IKK2nCA =
transgenic mice with neuron-specific expression of constitutively active
IKK2. Scale bar: 100 μm. (n = 4). * p < 0.05, ** p < 0.01, ns: non-significant.
P-values are derived from two-tailed-unpaired student’s t test.
Additional file 7: IKK2-CA expression in cortex and olfactory bulbi
does not result in structural degeneration. (A) Photomicrographs from
the nissl-stained cortex sections of 3, 6, 9M old control and IKK2nCA mice.
Black bars depict area for cortical thickness measurement. (B)
Quantification of cortical thickness measurement by ImageJ64 shows no
changes among the control and IKK2nCA mice in the analysed age
groups (n = 6-7 per age group). (C) Images of olfactory bulbi of 3, 6, 9M
old control and IKK2nCA mice. Glomerular layer (GL), rostral migratory
stream (RMS), External plexiform layer (EPL), mitral cell layer (MCL),
granule cell layer (GCL). (D) Thickness of GCL of olfactory bulbi was
measured using ImageJ64. IKK2nCA mice do not exhibit significant
alterations in the GCL as compared to the control mice (n = 4-7). (E)
Subregional analysis of Bcl2 and Bcl2l1 expression by qRT-PCR. Reduced
levels in the DG and CA-region of IKK2nCA = were detected for Bcl2l1
compared to the littermate controls at the age of 9M. Bcl2 expression
shows a tendency of reduction (n = 6). Co = wild type and single
transgenic littermate controls, IKK2nCA = transgenic mice with neuron-
specific expression of constitutively active IKK2. * p < 0.05, ** p < 0.01.
Scale bar: A = 100 μm, C = 50 μm.
Additional file 8 Transgene inactivation increases neurogenesis in
IKK2nCA mice. (A) Ki67 immunostaining of paraffin sections depicts
Ki67-positive cells in the GCL of IKK2nCA mice after 3 months of DOX
treatment. Inserts demonstrate magnified images of the marked areas (n = 4).
(B) Quantification of Ki67-positive cells in the GCL reveals a significant
higher number in the DOX-treated IKK2nCA mice as compared to
untreated age-matched IKK2nCA mice. (Co =wild type and single transgenic
littermate controls, IKK2nCA = transgenic mice with neuron-specific expression
of constitutively active IKK2. Scale bar: 50 μm. * p < 0.05, ** p< 0.01, ns:
non-significant. P-values are derived from two-tailed-unpaired student’s t test.
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